Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Novabase - Sociedade Gestora De Participacoes Sociais, S.A. | NVQ | 22. nov 2024 | 5.80 | -0.85 |
Novabay Pharmaceuticals | B9P | 22. nov 2024 | 2.80 | 0.00 |
Novacyt | NYZ | 22. nov 2024 | 0.55 | -0.72 |
Novagold Resources Inc. | NGR | 22. nov 2024 | 3.42 | +1.97 |
Novanta Inc. - | 1GSN | 22. nov 2024 | 157.00 | -0.63 |
Novartis AG | NOTA | 22. nov 2024 | 101.00 | +2.43 |
Novavax, Inc. | NVV1 | 22. nov 2024 | 8.20 | +3.59 |
Novem Group S.A. | NVM | 22. nov 2024 | 5.64 | +3.30 |
NOVINA S.A. E ZY 1,16 | T36 | 22. nov 2024 | 0.23 | +4.85 |
Novo Nordisk A/S | NOVA | 22. nov 2024 | 100.50 | +3.18 |
Novo Resources Corp | 1NOR | 22. nov 2024 | 0.05 | 0.00 |
NovoCure Limited - Ordinary Shares | 038 | 22. nov 2024 | 16.18 | +1.25 |
NOVONIX ADR | GC30 | 22. nov 2024 | 1.73 | -2.26 |
Novonix Limited | GC3 | 22. nov 2024 | 0.45 | -1.85 |
NOVOTEK AB B SK-,25 | Z9D | 22. nov 2024 | 5.82 | 0.00 |
Novozymes AS | NZM | 22. nov 2024 | 54.00 | 0.00 |
Novozymes B | NZM2 | 22. nov 2024 | 56.76 | +4.07 |
Novra Technologies Inc. | 7CV | 22. nov 2024 | 0.05 | 0.00 |
Novus Holdings Limited | N09 | 22. nov 2024 | 0.39 | -0.52 |
NOW Inc. | 11N | 22. nov 2024 | 13.60 | +1.49 |
NP3 Fastigheter | N33 | 22. nov 2024 | 21.25 | +5.72 |
NPC Inc | 59N | 22. nov 2024 | 5.65 | +3.67 |
NRC Group | 8NR | 22. nov 2024 | 0.29 | +1.77 |
NRG Energy Inc. | NRA | 22. nov 2024 | 92.14 | +3.16 |
NRJ Group | NR8 | 22. nov 2024 | 6.98 | -0.57 |
NRW Holdings Limited | 3NR | 22. nov 2024 | 2.36 | +0.85 |
Ns United Kaiun Kaisha, Ltd. | 8WN | 22. nov 2024 | 25.40 | +3.25 |
NSE SA | 7YM | 22. nov 2024 | 28.00 | 0.00 |
NSI N.V. | N4RN | 22. nov 2024 | 19.56 | +0.20 |
NSJ Gold Corp | 9PZ | 22. nov 2024 | 0.01 | +4.55 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.